Baxter Gets FDA OK of Higher-Protein Clinimix, Clinimix E Formulations

Baxter International Inc. Wednesday said the U.S. Food and Drug Administration approved new higher-protein formulations of its Clinimix and Clinimix injections for patients who need an intravenous administration of nutrition.

The Deerfield, Ill., medical-products company said the new formulations contain the highest protein level in any multi-chamber bag available in the U.S., making it easier to reach patient protein targets while delivering less fluid and dextrose than existing formulations.

Baxter said it will continue to provide existing formulations of Clinimix and Clinimix E for patients with lower protein needs. 

https://www.marketscreener.com/quote/stock/BAXTER-INTERNATIONAL-INC-11763/news/Baxter-International-Gets-FDA-OK-of-Higher-Protein-Clinimix-Clinimix-E-Formulations-31345920/